跳至主要内容
临床试验/NCT05383521
NCT05383521尚未招募不适用

Oral Tinidazole Treatment of Refractory Trichomonas Vaginitis

Shangrong Fan4 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20
试验地点
4
主要终点
Cure rate of refractory trichomoniasis

研究概览

简要总结

We compare two oral tinidazole regimens for refractory trichomonas vaginitis.

详细描述

Refractory trichomonas vaginitis has become a clinical problem, which has a direct impact on the health and life of patients. Refractory trichomonas vaginitis is mainly caused by drug resistance of trichomonas. Drug resistant trichomonas has appeared China. Increasing the dosage of anti trichomonal drugs is the main treatment method at present. The aim of this study was to evaluate the efficacy and safety of two oral tinidazole regimens for refractory trichomonas vaginitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women be at least 18 years of age
  • Failure of conventional treatment (recommended by guidelines including tinidazole, 2g once daily for 5-7 days)

排除标准

  • Allergy to metronidazole or tinidazol
  • Pregnant or nursing
  • HIV or other chronic disease

研究组 & 干预措施

Tinidazole 56

Experimental

Tinidazole , 2g, twice daily for 14 days. At the same time, metronidazole, 400 mg, once a day, vaginal administration, 14 days.

干预措施: Tinidazole 42 (Drug)

Tinidazole 42

Experimental

Tinidazole , 1g, three times daily for 14 days. At the same time, metronidazole, 400 mg, once a day, vaginal administration, 14 days.

干预措施: Tinidazole 56 (Drug)

结局指标

主要结局

Cure rate of refractory trichomoniasis

时间窗: 24 weeks

Evaluate the efficacy of oral tinidazole tablets in the treatment of refractory trichomoniasis.Diagnosis of vaginal trichomoniasis is performed by microscopy of vaginal secretions. Cure or failure was based on positive or negative T. vaginalis on vaginal secretions by microscopy examination.

次要结局

  • Safety of tinidazole tablets(24 weeks)

研究者

发起方
Shangrong Fan
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Shangrong Fan

Profesor

Peking University Shenzhen Hospital

研究点 (4)

Loading locations...

相似试验